Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022
XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and PLENVU® Research Posters Will Be Presented LAVAL, Quebec, May 18, 2022 — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and its gastroenterology business, Salix Pharmaceuticals, (“Salix”),…